510(k) K181464
K181464 is an FDA 510(k) premarket notification submitted by DiaSorin, Inc. for the device "LIAISON Helicobacter Antigen, LIAISON Helicobacter Antigen Control Set". The FDA issued a decision of Substantially Equivalent on August 31, 2018. The device falls under product code LYR (Helicobacter Pylori), a Class I device regulated under 21 CFR 866.3110. DiaSorin, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 31, 2018
- Date Received
- June 4, 2018
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Helicobacter Pylori
- Device Class
- Class I
- Regulation Number
- 866.3110
- Review Panel
- MI
- Submission Type